4//SEC Filing
Lenington Rachel 4
Accession 0001209191-23-004475
CIK 0001620463other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:45 PM ET
Size
5.5 KB
Accession
0001209191-23-004475
Insider Transaction Report
Form 4
Lenington Rachel
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-01-19+200,000→ 200,000 totalExercise: $3.37Exp: 2033-01-18→ Common Stock (200,000 underlying)
Footnotes (1)
- [F1]One thirty-sixth (1/36th) of the shares subject to the option will vest on February 19, 2023 and one thirty-sixth of the shares subject to the option will vest each month thereafter.
Documents
Issuer
Athira Pharma, Inc.
CIK 0001620463
Entity typeother
Related Parties
1- filerCIK 0001861194
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:45 PM ET
- Size
- 5.5 KB